This document aims to develop a set of criteria for a rational approach to the testing and assessment of bound residues. It may serve to complement and further specify the provisions of Volume 8 of the Rules Governing Medicinal Products in the European Union.
Keywords: Bioavailability, bound residues, extractable, consumer safety, maximum residue limit (MRL)